L04A Immunosuppressants
L04AA Selective immunosuppressants L04AA03 Antilymphocyte immunoglobulin (horse) L04AA04 Antithymocyte immunoglobulin (rabbit) L04AA06 Mycophenolic acid L04AA15 Alefacept L04AA19 Gusperimus L04AA22 Abetimus L04AA24 Abatacept L04AA28 Belatacept L04AA32 Apremilast L04AA40 Cladribine L04AA41 Imlifidase L04AA48 Belumosudil L04AA60 Remibrutinib L04AA61 Nerandomilast L04AA62 Tolebrutinib
L04AB Tumor necrosis factor alpha (TNF-α) inhibitors L04AB01 Etanercept L04AB02 Infliximab L04AB03 Afelimomab L04AB04 Adalimumab L04AB05 Certolizumab pegol L04AB06 Golimumab L04AB07 Opinercept
L04AC Interleukin inhibitors L04AC01 Daclizumab L04AC02 Basiliximab L04AC03 Anakinra L04AC04 Rilonacept L04AC05 Ustekinumab L04AC07 Tocilizumab L04AC08 Canakinumab L04AC09 Briakinumab L04AC10 Secukinumab L04AC11 Siltuximab L04AC12 Brodalumab L04AC13 Ixekizumab L04AC14 Sarilumab L04AC15 Sirukumab L04AC16 Guselkumab L04AC17 Tildrakizumab L04AC18 Risankizumab L04AC19 Satralizumab L04AC20 Netakimab L04AC21 Bimekizumab L04AC22 Spesolimab L04AC23 Olokizumab L04AC26 Goflikicept L04AC27 Cendakimab
L04AD Calcineurin inhibitors L04AD01 Ciclosporin L04AD02 Tacrolimus L04AD03 Voclosporin
L04AE Sphingosine 1-phosphate (S1P) receptor modulators L04AE01 Fingolimod L04AE02 Ozanimod L04AE03 Siponimod L04AE04 Ponesimod L04AE05 Etrasimod
L04AF Janus-associated kinase (JAK) inhibitors L04AF01 Tofacitinib L04AF02 Baricitinib L04AF03 Upadacitinib L04AF04 Filgotinib L04AF05 Itacitinib L04AF06 Peficitinib L04AF07 Deucravacitinib L04AF08 Ritlecitinib L04AF09 Deuruxolitinib
L04AG Monoclonal antibodies L04AG01 Muromonab-CD3 L04AG02 Efalizumab L04AG03 Natalizumab L04AG04 Belimumab L04AG05 Vedolizumab L04AG06 Alemtuzumab L04AG07 Begelomab L04AG08 Ocrelizumab L04AG09 Emapalumab L04AG10 Inebilizumab L04AG11 Anifrolumab L04AG12 Ofatumumab L04AG13 Teprotumumab L04AG14 Ublituximab L04AG15 Divozilimab L04AG17 Seniprutug L04AG18 Sibeprenlimab L04AG19 Axatilimab
L04AH Mammalian target of rapamycin (mTOR) kinase inhibitors L04AH01 Sirolimus L04AH02 Everolimus
L04AJ Complement inhibitors L04AJ01 Eculizumab L04AJ02 Ravulizumab L04AJ03 Pegcetacoplan L04AJ04 Sutimlimab L04AJ05 Avacopan L04AJ06 Zilucoplan L04AJ07 Crovalimab L04AJ08 Iptacopan L04AJ09 Danicopan L04AJ10 Vilobelimab L04AJ11 Pozelimab
L04AK Dihydroorotate dehydrogenase (DHODH) inhibitors L04AK01 Leflunomide L04AK02 Teriflunomide
L04AL Neonatal fragment crystallizable receptor (FcRn) inhibitors L04AL01 Efgartigimod alfa L04AL02 Rozanolixizumab L04AL03 Nipocalimab
L04AX Other immunosuppressants L04AX01 Azathioprine L04AX02 Thalidomide L04AX03 Methotrexate L04AX04 Lenalidomide L04AX05 Pirfenidone L04AX06 Pomalidomide L04AX07 Dimethyl fumarate L04AX08 Darvadstrocel L04AX09 Diroximel fumarate L04AX10 Tegomil fumarate L04AX11 Monomethyl fumarate
References